Retrospective Analysis of Patients Re-treated With Lutetium-177 DOTATATE (Lutathera®)

NCT05816720 · clinicaltrials.gov ↗

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuroendocrine Tumor

Interventions

DRUG: Lutetium-177 DOTATATE

Sponsor

Novartis Pharmaceuticals